Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fletcher

Showing results (251-260 of 326) with videos related to

Pageof 33
Sort By:
The Journal of Infectious Diseases|October 7, 2000
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359R M Gulick, X J Hu, S A Fiscus, et al.
World Journal of Gastroenterology|August 27, 2021
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axisSamuel D Johnson, Omalla A Olwenyi, Namita Bhyravbhatla, et al.
AIDS (London, England)|July 20, 2002
Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in UgandaLaura A Guay, Philippa Musoke, David L Hom, et al.
Frontiers in Immunology|December 5, 2022
Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in SIV infectionHoward S Fox, Meng Niu, Brenda M Morsey, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2007
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infectionJennifer J Kiser, Courtney V Fletcher, Patricia M Flynn, et al.
Elife|January 23, 2026
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIVCéline Fombellida-Lopez, Aurelija Valaitienė, Lee Winchester, et al.
Cell Reports|March 28, 2019
Prdm12 Directs Nociceptive Sensory Neuron Development by Regulating the Expression of the NGF Receptor TrkASimon Desiderio, Simon Vermeiren, Claude Van Campenhout, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIVCéline Fombellida-Lopez, Aurelija Valaitienė, Lee Winchester, et al.
Clinical Pharmacology and Therapeutics|July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 InfectionRachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
The Lancet. Respiratory Medicine|November 14, 2022
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trialToby M Maher, Veronica A Tudor, Peter Saunders, et al.
Pageof 33

Showing results (251-260 of 326) with videos related to

Sort By:
Pageof 33
The Journal of Infectious Diseases|October 7, 2000
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359R M Gulick, X J Hu, S A Fiscus, et al.
World Journal of Gastroenterology|August 27, 2021
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axisSamuel D Johnson, Omalla A Olwenyi, Namita Bhyravbhatla, et al.
AIDS (London, England)|July 20, 2002
Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in UgandaLaura A Guay, Philippa Musoke, David L Hom, et al.
Frontiers in Immunology|December 5, 2022
Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in SIV infectionHoward S Fox, Meng Niu, Brenda M Morsey, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2007
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infectionJennifer J Kiser, Courtney V Fletcher, Patricia M Flynn, et al.
Elife|January 23, 2026
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIVCéline Fombellida-Lopez, Aurelija Valaitienė, Lee Winchester, et al.
Cell Reports|March 28, 2019
Prdm12 Directs Nociceptive Sensory Neuron Development by Regulating the Expression of the NGF Receptor TrkASimon Desiderio, Simon Vermeiren, Claude Van Campenhout, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIVCéline Fombellida-Lopez, Aurelija Valaitienė, Lee Winchester, et al.
Clinical Pharmacology and Therapeutics|July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 InfectionRachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
The Lancet. Respiratory Medicine|November 14, 2022
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trialToby M Maher, Veronica A Tudor, Peter Saunders, et al.
Pageof 33